Takeda Completes Acquisition of Brazil's Multilab


Osaka, Japan, July 3, 2012 – Takeda Pharmaceutical Company Limited (Osaka, Japan, “Takeda”) today announced that its wholly-owned subsidiary, Takeda Farmacêutica Brasil Ltda. (São Paulo, Brazil, “Takeda Brazil”), has completed the acquisition of Multilab. The acquisition significantly strengthens Takeda’s existing presence in Brazil, positioning it as one of the top ten pharmaceutical companies in the country(1) . Multilab brings a diverse portfolio of complementary branded generics and OTC products, including Multigrip®, the country’s best-selling OTC product for cold and flu treatment in units (2) . OTC products represent approximately 30% of the total Brazilian pharmaceutical market, and the addition of Multigrip® will strengthen Takeda’s current OTC portfolio consisting of anti-pain (Neosalodina®), digestive support (Eparema®), and dermatological (Nebacetin®) treatments.

Read more


Top of page

Takeda Pharma